Human medicines European public assessment report (EPAR): Paxneury, guanfacine, Date of authorisation: 26/02/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Veyvondi, vonicog alfa, Date of authorisation: 31/08/2018, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Erbitux, cetuximab, Date of authorisation: 29/06/2004, Revision: 36, Status: Authorised

Questions and answers: Article 31 non-pharmacovigilance referrals

Questions and answers on Article 31 non-pharmacovigilance referrals

Recommendations of the Executive Steering Group on the Shortages and Safety of Medicinal Products on shortages of intravenous ifosfamide and cyclophosphamide

Human medicines European public assessment report (EPAR): Yartemlea, Narsoplimab, Status: Opinion under re-examination

EMA and EISMEA boost cooperation to accelerate health innovations

ICH E6 Good clinical practice - Scientific guideline

PSUSA/00000148/202506